MRF-Logo2019-Horizontal-RGB
First Drug To Help Melanoma Of The Eye
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

First Drug To Help Melanoma Of The Eye

› Forums › Ocular Melanoma Community › First Drug To Help Melanoma Of The Eye

  • This topic is empty.
  • Post
    • June 19, 2013 at 5:13 am
    JerryfromFauq
    Participant

      AstraZeneca's experimental drug, selumetinib, is the first targeted medication to show a significant clinical benefit for patients with melanoma of the eye (metastatic uveal melanoma), researchers from the Memorial Sloan-Kettering Cancer Center explained at the 49th annual meeting of the American Society of Clinical Oncology (ASCO), in Chicago, Illinois.

      The scientists say that their findings will probably change clinical practice for patients with metastatic uveal melanoma, which to date has been an "untreatable disease". Uveal melanoma is a rare disease, there are 2,500 diagnoses annually in the USA, half of whom develop metastatic disease. For decades, survival of patients with metastasis has remained obstinately at 9 to 12 months.

    Tagged: ,

    • You must be logged in to reply to this topic.
    About the MRF Patient Forum

    The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

    The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

    Popular Topics